ANGN

Angion Biomedica (ANGN)

Angion Biomedica Corporation

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:ANGN

1 2 3 4 5 6 7 8 9 10 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2024/04/29	20 : 00	Edgar (US Regulatory)	Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]	NASDAQ:ANGN	Angion Biomedica Corporation
2024/04/06	05 : 33	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:ANGN	Angion Biomedica Corporation
2024/03/30	04 : 28	Edgar (US Regulatory)	Form S-8 - Securities to be offered to employees in employee benefit plans	NASDAQ:ANGN	Angion Biomedica Corporation
2024/03/30	04 : 26	Edgar (US Regulatory)	Form S-3 - Registration statement under Securities Act of 1933	NASDAQ:ANGN	Angion Biomedica Corporation
2024/03/30	02 : 58	Edgar (US Regulatory)	Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]	NASDAQ:ANGN	Angion Biomedica Corporation
2024/03/29	21 : 35	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:ANGN	Angion Biomedica Corporation
2024/03/21	05 : 37	Edgar (US Regulatory)	Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]	NASDAQ:ANGN	Angion Biomedica Corporation
2024/03/21	05 : 28	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:ANGN	Angion Biomedica Corporation
2024/03/18	21 : 05	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:ANGN	Angion Biomedica Corporation
2024/02/05	20 : 01	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:ANGN	Angion Biomedica Corporation
2024/02/05	20 : 01	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:ANGN	Angion Biomedica Corporation
2024/02/05	20 : 01	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:ANGN	Angion Biomedica Corporation
2024/02/05	20 : 01	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:ANGN	Angion Biomedica Corporation
2024/02/02	22 : 51	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:ANGN	Angion Biomedica Corporation
2024/01/17	22 : 35	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:ANGN	Angion Biomedica Corporation
2024/01/16	21 : 59	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:ANGN	Angion Biomedica Corporation
2024/01/09	22 : 11	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:ANGN	Angion Biomedica Corporation
2024/01/06	06 : 05	Edgar (US Regulatory)	Form D - Notice of Exempt Offering of Securities	NASDAQ:ANGN	Angion Biomedica Corporation
2023/12/30	07 : 05	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:ANGN	Angion Biomedica Corporation
2023/12/30	07 : 05	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:ANGN	Angion Biomedica Corporation
2023/12/27	06 : 29	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:ANGN	Angion Biomedica Corporation
2023/12/27	06 : 25	Edgar (US Regulatory)	Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]	NASDAQ:ANGN	Angion Biomedica Corporation
2023/12/22	23 : 06	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:ANGN	Angion Biomedica Corporation
2023/11/13	22 : 45	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:ANGN	Angion Biomedica Corporation
2023/11/10	06 : 41	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:ANGN	Angion Biomedica Corporation
2023/11/04	06 : 10	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:ANGN	Angion Biomedica Corporation
2023/10/20	20 : 58	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:ANGN	Angion Biomedica Corporation
2023/10/12	20 : 59	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:ANGN	Angion Biomedica Corporation
2023/09/07	21 : 00	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:ANGN	Angion Biomedica Corporation
2023/08/31	05 : 33	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:ANGN	Angion Biomedica Corporation